Cronos Group Inc.
TSX:CRON.TODrug Manufacturers - Specialty & Generic
-$0.01 today
- Market cap
- $1.67B
- Beta
- 1.25
- P/E (TTM)
- -488.1
- EPS (TTM)
- -$0.01
Volume 0.15M
Average 0.19M
Returns on capital
Cronos Group Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-0.9%
avg -0.1%
ROIC
-0.3%
avg -7.8%
ROA
-0.8%
avg -0.9%
Analysis
ROIC is currently the strongest return metric at -0.3% versus its period average of -7.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Michael Ryan Gorenstein | President, Chief Executive Officer & Chairman | USD 3M | 39 | — | — |
Anna Shlimak | Chief Financial Officer | USD 1.12M | 40 | — | — |
Jeffrey David Jacobson | Chief Growth Officer | USD 1.08M | 40 | — | — |
Adam Wagner | General Manager of Cronos Israel | USD 894.86K | 43 | — | — |
Shannon Buggy | Senior Vice President & Global Head of People | USD 744.32K | 56 | — | — |
Christopher Martens | General Manager | — | — | — | — |
Arye Weigensberg | Senior Vice President and Head of Research & Development | — | 43 | — | — |
Harrison Aaron | Senior Director of Investor Relations & Corporate Development | — | — | — | — |
Jared Matthew Kenost | Principal Accounting Officer, Vice President & Controller | — | — | — | — |
Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary | — | 36 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +19.4% | +16.0% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +19.4% over three years. Forward estimates point to Revenue at +16.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Cronos Group Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about CRON.TO's management, answered from reported figures.
Who manages CRON.TO?
Cronos Group Inc. (CRON.TO) lists 10 active executives. The top listed executive is Christopher Martens, General Manager.
Continue the stock analysis
Jump to another research area for this company.